Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20268807

Treatment Options in Alzheimer's Disease : Maximizing Benefit, Managing Expectations

Author
FARLOW, Martin R1 ; MILLER, Michael L2 ; PEJOVIC, Vojislav2
[1] Indiana University School of Medicine, Indianapolis, Ind, United States
[2] Prescott Medical Communications Group, Chicago, Ill, United States
Source

Dementia and geriatric cognitive disorders. 2008, Vol 25, Num 5, pp 408-422, 15 p ; ref : 183 ref

ISSN
1420-8008
Scientific domain
Gerontology geriatrics; Neurology; Psychology, psychopathology, psychiatry
Publisher
Karger, Basel
Publication country
Switzerland
Document type
Article
Language
English
Author keyword
Alzheimer's disease Antioxidants Cholinesterase inhibitors Combination therapy Ginkgo biloba Memantine Pharmacotherapy
Keyword (fr)
Antialzheimer Antioxydant Antiparkinsonien Association médicamenteuse Cholinesterase Démence d'Alzheimer Maladie dégénérative Mémantine Pathologie du système nerveux Traitement associé Trouble cognitif Antagoniste Carboxylic ester hydrolases Dérivé de l'amantadine Enzyme Esterases Hydrolases Pathologie de l'encéphale Pathologie du système nerveux central Récepteur NMDA Récepteur glutamate
Keyword (en)
Antialzheimer agent Antioxidant Antiparkinson agent Drug combination Cholinesterase Alzheimer disease Degenerative disease Memantine Nervous system diseases Combined treatment Cognitive disorder Antagonist Carboxylic ester hydrolases Amantadine derivatives Enzyme Esterases Hydrolases Cerebral disorder Central nervous system disease NMDA receptor Glutamate receptor
Keyword (es)
Antialzheimer Antioxidante Antiparkinsoniano Asociación medicamentosa Cholinesterase Demencia Alzheimer Enfermedad degenerativa Memantina Sistema nervioso patología Tratamiento asociado Trastorno cognitivo Antagonista Carboxylic ester hydrolases Amantadina derivada Enzima Esterases Hydrolases Encéfalo patología Sistema nervosio central patología Receptor NMDA Receptor glutámato
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02F Cardiovascular system / 002B02F04 Vasodilator agents. Cerebral vasodilators

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17G Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases

Discipline
Neurology Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
20268807

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web